Capital 10X sits down with Emerald Health Therapeutics
Hertel provides an overview of Emerald Health Therapeutics; a Canadian licensed producer of cannabis products led by a team of life science professionals. He details their “defined dose” approach to developing differentiated products for medical- and adult-use customers.
This is followed by a discussion of the impressive financial results of their Pure SunFarms JV, expanding operations, new c-suite additions, and upcoming catalysts.
The opinions provided in this article are those of the author and do not constitute investment advice. Readers should assume that the author and/or employees of Capital 10X hold positions in the company or companies mentioned in the article. For more information, please see our Content Disclaimer.